TGF‐β1 Pathway as a New Target for Neuroprotection in Alzheimer's Disease

Alzheimer's disease (AD) is a neurodegenerative disorder that affects more than 37 million people worldwide. Current drugs for AD are only symptomatic, but do not interfere with the underlying pathogenic mechanisms of the disease. AD is characterized by the presence of ß‐amyloid (Aβ) plaques, n...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:CNS Neurosci Ther
Hlavní autoři: Caraci, Filippo, Battaglia, Giuseppe, Bruno, Valeria, Bosco, Paolo, Carbonaro, Viviana, Giuffrida, Maria Laura, Drago, Filippo, Sortino, Maria Angela, Nicoletti, Ferdinando, Copani, Agata
Médium: Artigo
Jazyk:Inglês
Vydáno: Blackwell Publishing Ltd 2009
Témata:
Reviews
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6493850/
https://ncbi.nlm.nih.gov/pubmed/19925479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1755-5949.2009.00115.x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky